您的位置: 首页 > 农业专利 > 详情页

ANTICORPS ANTI-CD73 HUMAIN
专利权人:
ASTELLAS PHARMA INC.
发明人:
SATO, MASAHITO,TOYONAGA, HANAE,OSAKI, FUMIO,EGUCHI, TOMOHIRO
申请号:
CA3046432
公开号:
CA3046432A1
申请日:
2017.12.12
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
[Problem] To provide an anti-human CD73 antibody which is potentiated compared with the conventional antibodies and has an ability to recover a suppressed function of a human T cell which is suppressed in an AMP-dependent manner. [Solution] Provided is an anti-human CD73 antibody containing: a heavy-chain variable region which contains CDR1 comprising an amino acid sequence composed of amino acid residues lying between position-31 to position-35 in SEQ ID NO: 2, CDR2 comprising an amino acid sequence composed of amino acid residues lying between position-50 to position-66 in SEQ ID NO: 2 and CDR3 comprising an amino acid sequence composed of amino acid residues lying between position-99 to position-112 in SEQ ID NO: 2; and a light-chain variable region which contains CDR1 comprising an amino acid sequence composed of amino acid residues lying between position-24 to position-34 in SEQ ID NO: 4, CDR2 comprising an amino acid sequence composed of amino acid residues lying between position-50 to position-56 in SEQ ID NO: 4, and CDR3 comprising an amino acid sequence composed of amino acid residues lying between position-89 to position-98 in SEQ ID NO: 4.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充